APLS
NASDAQ · Biotechnology
Apellis Pharmaceuticals Inc
$41.03
-0.03 (-0.07%)
Analyst Consensus
Hold
27
Analysts
High
Coverage
Price Target
Analyst Price Target
-45.1% upside
Low Target
$12.93
Average Target
$22.54
High Target
$29.12
Current Price
$41.03
Current
$41.03
$41.03
Target
$22.54
$22.54
$12.93
$22.54 avg
$29.12
Scenario Analysis
Bear Case
$12.93
-68.5%
Low target
Base Case
$22.54
-45.1%
Avg target
Bull Case
$29.12
+-29.0%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$41.14
-0.3% from high
52-Week Low
$16.83
+143.8% from low
50-Day SMA
$33.20
+23.6% vs SMA
200-Day SMA
$26.08
+57.3% vs SMA
RSI (14)
58.7
Neutral
Target vs 52W High
$22.54
-45.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |